|
ZA9609618B
|
|
A process for producing an undenatured whey protein concentrate.
|
|
CA2165937A1
|
|
Process for producing an undenatured whey protein concentrate
|
|
ZA9409789B
|
|
Process for making undenatured whey protein concentrate
|
|
CA2151506A1
|
|
Process for producing an undenatured whey protein concentrate
|
|
US5888552A
|
|
Anti-cancer therapeutic compositions containing whey protein concentrate
|
|
IL106576D0
|
|
Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer
|
|
CA2090377A1
|
|
Anti-cancer therapeutic compositions for prophylaxis or for treatment of chemically induced cancer
|
|
NZ243860A
|
|
Increasing glutathione levels in human and animal organs using whey protein concentrate
|
|
US5456924A
|
|
Method of treatment of HIV-seropositive individuals with dietary whey proteins
|
|
US5230902A
|
|
Undenatured whey protein concentrate to improve active systemic humoral immune response
|
|
CA1338682C
|
|
Biologically active undenatured whey protein concentrate as food supplement
|
|
CA1333471C
|
|
Whey protein concentrate as food supplement
|
